Stroke Taste Videos

Chronic neurological dysfunction produced by stroke and brain injury has long been thought to be irreversible. A new scientific discovery by the INR, as documented in the videos below, now promises to change current thinking about the potential for recovery of function, even years after the acute event. Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR.

Literature reference:

Tobinick, E., N.M. Kim, G. Reyzin, H. Rodriguez-Romanacce, and V. Depuy, Selective TNF Inhibition for Chronic Stroke and Traumatic Brain Injury : An Observational Study Involving 629 Consecutive Patients Treated with Perispinal Etanercept. CNS Drugs, 2012. 26(12): p. 1051-70.


From Invercargill, New Zealand nearly 3 years after stroke

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR.


Taste, Pain, Walking, and Hand Function Improvement after Treatment at INR

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR.


Immediate neurological improvement 16 months after stroke, November 14, 2014

November 14, 2014: 16 months after stroke, immediate neurological improvement beginning within minutes of treatment at the Institute of Neurological Recovery in Boca Raton, Florida. Patient accompanied by her two daughters. Improvements noted in chronic post-stroke pain, chronic post-stroke aphasia, taste (right side of tongue), brain “fog”, and walking.

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment for these indications is innovative (“off-label”). Please see the Terms of Use. The method of off-label treatment utilized is a patented invention of the INR.